Company registration number 05654323 (England and Wales)
HEALTHMATTERS GROUP LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
HEALTHMATTERS GROUP LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
HEALTHMATTERS GROUP LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Fixed assets
Tangible assets
4
220
1,183
Investments
5
100
100
320
1,283
Current assets
Debtors
7
31,568
75,929
Cash at bank and in hand
50,667
12,595
82,235
88,524
Creditors: amounts falling due within one year
8
(97,643)
(122,267)
Net current liabilities
(15,408)
(33,743)
Net liabilities
(15,088)
(32,460)
Capital and reserves
Called up share capital
10
104
100
Share premium account
29,996
-
0
Equity reserve
11
-
0
15,000
Profit and loss reserves
(45,188)
(47,560)
Total equity
(15,088)
(32,460)

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved and signed by the director and authorised for issue on 15 August 2025
Mr J R Lamper
Director
Company registration number 05654323 (England and Wales)
HEALTHMATTERS GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

HealthMatters Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is c/o Craufurd Hale Group, Ground Floor, Arena Court, Crown Lane, MAIDENHEAD, SL6 8QZ.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Going concern

A true t the time of approving the financial statements, t he director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he director continues to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Turnover is recognised at the fair value of the consideration received or receivable for services provided in the normal course of business.

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion can be estimated reliably.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
20% straight line

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.5
Fixed asset investments

Interests in subsidiaries are measured at cost.

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.6
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.

HEALTHMATTERS GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
1.7
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are recognised at transaction price including transaction costs.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities as payment is due within one year or less.

1.8
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.9
Taxation

The tax expense represents the sum of the tax currently payable.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

1.10
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense.

1.11
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.12
Share-based payments

The company has issued share options to certain individuals. These financial statements have been prepared without recognition of any potential share based payment costs as an expense.

HEALTHMATTERS GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
4
7
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 January 2024
11,202
Disposals
(10,509)
At 31 December 2024
693
Depreciation and impairment
At 1 January 2024
10,019
Depreciation charged in the year
594
Eliminated in respect of disposals
(10,140)
At 31 December 2024
473
Carrying amount
At 31 December 2024
220
At 31 December 2023
1,183
5
Fixed asset investments
2024
2023
£
£
Shares in group undertakings and participating interests
100
100
HEALTHMATTERS GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 5 -
6
Subsidiaries

Details of the company's subsidiaries at 31 December 2024 are as follows:

Name of undertaking
Registered office
Nature of business
Class of
% Held
shares held
Direct
WeightMatters Limited
England and Wales
Dormant
Ordinary
100.00
The aggregate capital and reserves and the result for the year of the subsidiaries noted above was as follows:
Name of undertaking
Capital and Reserves
Profit/(Loss)
£
£
WeightMatters Limited
100
-
0
7
Debtors
2024
2023
Amounts falling due within one year:
£
£
Trade debtors
15,296
20,119
Other debtors
16,272
55,810
31,568
75,929
8
Creditors: amounts falling due within one year
2024
2023
£
£
Bank loans and overdrafts
-
0
915
Trade creditors
38,777
38,330
Amounts owed to group undertakings
100
100
Taxation and social security
1,020
97
Other creditors
57,746
82,825
97,643
122,267
9
Share-based payment transactions
Number of share options
Weighted average exercise price
2024
2023
2024
2023
Number
Number
£
£
Outstanding at 1 January 2024 and 31 December 2024
3,150
3,150
1.00
1.00
Exercisable at 31 December 2024
1,050
-
0
1.00
-
0
HEALTHMATTERS GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
9
Share-based payment transactions
(Continued)
- 6 -

The company has not recognised an expense in relation to share options.

On 30 December 2021 options were granted for 1,050 B Ordinary shares of £0.001 each to three individuals, therefore options totalling 3,150 B Ordinary shares.

The options outstanding at 31 December 2023 and 31 December 2024 had an exercise price of £1.00 per option share.

350 of each of the options, 1,050 in total, become exercisable by each option holder on 31 December 2024, 31 December 2025 and 31 December 2026.

10
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of 0.1p each
100,000
100,000
100
100
B Ordinary shares of 0.1p each
3,627
0
4
-
0
103,627
100,000
104
100

During the year 3,627 B Ordinary shares of £0.001 each were issued for a consideration of £30,000 resulting in a premium of £29,664.

With the exception of entitlement to receive dividends, the ordinary shares and B ordinary shares rank pari passu in all aspects, including the right to attend and vote at general meetings.

11
Equity reserve

In the previous year the company received cash in relation to a share subscription agreement. The company could not be required to repay the cash and recognised an increase in equity to the extent of the consideration received at the previous balance sheet date.

12
Directors' transactions

Included in other debtors is the balance of £0 (2023 - £44,362) on the director's current account. Interest is charged at a rate of 2.25%. There are no formal repayment terms.

Included in other creditors is the balance of £12,568 (2023 - £0) on the director's current account. The balance is interest free and there are no formal repayment terms.

2024-12-31 2024-01-01 false false false 15 August 2025 CCH Software CCH Accounts Production 2025.200 No description of principal activity Mr J R Lamper 2025-09-05 05654323 2024-01-01 2024-12-31 05654323 2024-12-31 05654323 2023-12-31 05654323 core:OtherPropertyPlantEquipment 2024-12-31 05654323 core:OtherPropertyPlantEquipment 2023-12-31 05654323 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 05654323 core:CurrentFinancialInstruments core:WithinOneYear 2023-12-31 05654323 core:ShareCapital 2024-12-31 05654323 core:ShareCapital 2023-12-31 05654323 core:SharePremium 2024-12-31 05654323 core:SharePremium 2023-12-31 05654323 core:OtherReservesSubtotal 2024-12-31 05654323 core:OtherReservesSubtotal 2023-12-31 05654323 core:RetainedEarningsAccumulatedLosses 2024-12-31 05654323 core:RetainedEarningsAccumulatedLosses 2023-12-31 05654323 core:ShareCapitalOrdinaryShareClass2 2024-12-31 05654323 core:ShareCapitalOrdinaryShareClass2 2023-12-31 05654323 core:ShareCapitalOrdinaryShareClass3 2024-12-31 05654323 core:ShareCapitalOrdinaryShareClass3 2023-12-31 05654323 core:ShareCapitalOrdinaryShares 2024-12-31 05654323 core:ShareCapitalOrdinaryShares 2023-12-31 05654323 bus:Director1 2024-01-01 2024-12-31 05654323 core:FurnitureFittings 2024-01-01 2024-12-31 05654323 2023-01-01 2023-12-31 05654323 core:OtherPropertyPlantEquipment 2023-12-31 05654323 core:OtherPropertyPlantEquipment 2024-01-01 2024-12-31 05654323 core:Subsidiary1 2024-01-01 2024-12-31 05654323 core:Subsidiary1 1 2024-01-01 2024-12-31 05654323 core:Subsidiary1 2024-12-31 05654323 core:CurrentFinancialInstruments 2024-12-31 05654323 core:CurrentFinancialInstruments 2023-12-31 05654323 core:WithinOneYear 2024-12-31 05654323 core:WithinOneYear 2023-12-31 05654323 2023-12-31 05654323 2022-12-31 05654323 bus:OrdinaryShareClass2 2024-01-01 2024-12-31 05654323 bus:OrdinaryShareClass3 2024-01-01 2024-12-31 05654323 bus:OrdinaryShareClass2 2024-12-31 05654323 bus:OrdinaryShareClass2 2023-12-31 05654323 bus:OrdinaryShareClass3 2024-12-31 05654323 bus:OrdinaryShareClass3 2023-12-31 05654323 bus:AllOrdinaryShares 2024-12-31 05654323 bus:AllOrdinaryShares 2023-12-31 05654323 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 05654323 bus:FRS102 2024-01-01 2024-12-31 05654323 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 05654323 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 05654323 bus:FullAccounts 2024-01-01 2024-12-31 xbrli:pure xbrli:shares iso4217:GBP